The Biosimilars Alliance is the bridge between manufacturing and clinical efficacy, offering:
- Early Safety Assessment
- Immunotoxicology
- Bioanalytical and immunogenicity assay development (preclinical and clinical)
- Developing preclinical and clinical study designs
- Monitoring and quantification of antigenicity
- Regulatory guidance and preparation of clinical programs
- Program Management
For a graphical representation, click here